D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage company focused on unlocking the full potential of genetic medicines to treat large market diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback